Anti-Inflammatory Biologics Market Report 2026
Download Free Sample Buy Now
Anti-Inflammatory Biologics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anti-Inflammatory Biologics Market Report 2026

Global Outlook – By Drug Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, B-Cell Inhibitors, T-Cell Inhibitors, Other Drug Classes), By Route Of Administration (Oral, Injection, Intravenous, Subcutaneous), By Application (Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End-Users (Hospital, Clinics, Home Care Settings, Research And Academic Institutes) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Anti-Inflammatory Biologics Market Overview

• Anti-Inflammatory Biologics market size has reached to $118.02 billion in 2025

• Expected to grow to $180.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%

• Growth Driver: Rising Prevalence Of Arthritis Fueling The Growth Of The Market Due To Increasing MSK Disease Burden

• Market Trend: Targeted IL-6 Therapies Offer Safer Relief For Chronic Inflammatory Conditions

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Anti-Inflammatory Biologics Market?

Anti-inflammatory biologics are therapeutic drugs derived from living organisms that target specific components of the immune system to reduce inflammation. They are commonly used to treat chronic inflammatory conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease by inhibiting cytokines or immune cells responsible for the inflammatory response.

The main drug classes of anti-inflammatory biologics are tumor necrosis factor inhibitors, interleukin inhibitors, B-cell inhibitors, T-cell inhibitors, and others. Tumor necrosis factor inhibitors are a class of biologic drugs that block the activity of tumor necrosis factor-alpha, a substance in the body that causes inflammation, to help reduce symptoms in autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease. These medications are administered through various routes of administration such as oral, injection, intravenous, and subcutaneous. They are commonly used for a range of applications, including rheumatoid arthritis, inflammatory bowel disease, psoriasis, and others, and are provided through multiple distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others. They serve a diverse group of end users such as hospitals, clinics, home care settings, and research and academic institutes.

Anti-Inflammatory Biologics Market Global Report 2026 Market Report bar graph

What Is The Anti-Inflammatory Biologics Market Size and Share 2026?

The anti-inflammatory biologics market size has grown strongly in recent years. It will grow from $118.02 billion in 2025 to $128.84 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to limited availability of biologics, reliance on traditional anti-inflammatory drugs, increasing prevalence of rheumatoid arthritis and psoriasis, growth of hospital and clinic infrastructure, rising investment in immunology research.

What Is The Anti-Inflammatory Biologics Market Growth Forecast?

The anti-inflammatory biologics market size is expected to see strong growth in the next few years. It will grow to $180.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to development of next-generation cytokine inhibitors, expansion of home care and self-administration options, increasing regulatory approvals and faster clinical trial processes, rising investment in precision medicine and biologics R&D, growing partnerships between pharma and biotech companies. Major trends in the forecast period include rising adoption of targeted biologics for chronic inflammatory diseases, expansion of subcutaneous and injectable drug delivery, growing clinical trials and research for novel anti-inflammatory biologics, increased focus on personalized treatment plans, rising awareness and access to biologics in emerging markets.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Anti-Inflammatory Biologics Market Segmentation

1) By Drug Class: Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, B-Cell Inhibitors, T-Cell Inhibitors, Other Drug Classes

2) By Route Of Administration: Oral, Injection, Intravenous, Subcutaneous

3) By Application: Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End-Users: Hospital, Clinics, Home Care Settings, Research And Academic Institutes

Subsegments:

1) By Tumor Necrosis Factor Inhibitors: Adalimumab, Infliximab, Etanercept, Golimumab, Certolizumab Pegol

2) By Interleukin Inhibitors: Interleukin-1 Inhibitors, Interleukin-6 Inhibitors, Interleukin -12 Or 23 Inhibitors, Interleukin -17 Inhibitors, Interleukin -23 Inhibitors

3) By B-Cell Inhibitors: Rituximab, Ocrelizumab, Ofatumumab

4) By T-Cell Inhibitors: Abatacept, Alefacept

5) By Other Drug Classes: Janus Kinase Inhibitors, Anti-IgE And Other Biologics

What Is The Driver Of The Anti-Inflammatory Biologics Market?

The rising prevalence of arthritis is expected to propel the growth of the anti-inflammatory biologics market going forward. Arthritis refers to inflammation or swelling of one or more joints, causing pain, stiffness, and reduced movement, often worsening with age. The rising prevalence of arthritis is primarily due to increasing obesity rates, as excess body weight places additional stress on joints, leading to inflammation and joint degeneration. Anti-inflammatory biologics are useful for arthritis by targeting specific components of the immune system to reduce inflammation, slow joint damage, relieve symptoms, and improve physical function and quality of life for people with moderate to severe arthritis. For instance, in January 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2023, 18.4% of people aged 16 and over reported having a long-term MSK condition, up from 17.6% in 2022. Therefore, the rising prevalence of arthritis is driving the growth of the anti-inflammatory biologics industry.

Key Players In The Global Anti-Inflammatory Biologics Market

Major companies operating in the anti-inflammatory biologics market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, AbbVie Inc, Sanofi S.A, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc, UCB S.A

Global Anti-Inflammatory Biologics Market Trends and Insights

Major companies operating in the anti-inflammatory biologics market are focusing on developing innovative solutions, such as interleukin-6 (IL-6) receptor antagonists, to target chronic inflammatory diseases with greater specificity and reduced side effects. Interleukin-6 (IL-6) receptor antagonists are biologic drugs that block the IL-6 receptor to reduce inflammation and immune response in conditions such as rheumatoid arthritis. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, received approval from the US Food and Drug Administration (FDA) for Kevzara as the first and only biologic treatment indicated for patients with polymyalgia rheumatica (PMR) who do not respond adequately to corticosteroids. Kevzara is a fully human monoclonal antibody that blocks the IL-6 receptor, helping to reduce inflammation linked to PMR, a condition that causes muscle pain and stiffness, mainly in older adults. Unlike traditional steroids, which carry risks such as osteoporosis and diabetes with prolonged use, Kevzara provides a more targeted, steroid-sparing approach that supports improved patient outcomes and enhanced long-term safety.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Anti-Inflammatory Biologics Market?

In October 2023, Amgen Inc., a U.S.-based biopharmaceutical company, acquired Horizon Therapeutics plc for $27.8 billion. With this acquisition, Amgen aims to strengthen its leadership in innovative medicines for serious diseases, particularly by expanding its portfolio in rare and autoimmune conditions, accelerating growth, and reaching more patients worldwide with first-in-class therapies. Horizon Therapeutics plc is an Ireland-based company that is developing several anti-inflammatory biologics.

Regional Insights

North America was the largest region in the anti-inflammatory biologics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Inflammatory Biologics Market?

The anti-inflammatory biologics market consists of sales of adalimumab, etanercept, infliximab, ustekinumab, and secukinumab. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-Inflammatory Biologics Market Report 2026?

The anti-inflammatory biologics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-inflammatory biologics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anti-Inflammatory Biologics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $128.84 billion
Revenue Forecast In 2035 $180.93 billion
Growth Rate CAGR of 9.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route Of Administration, Application, Distribution Channel, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson And Johnson, Roche Holding AG, AbbVie Inc, Sanofi S.A, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc, UCB S.A
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anti-Inflammatory Biologics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anti-Inflammatory Biologics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anti-Inflammatory Biologics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anti-Inflammatory Biologics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Biologics For Chronic Inflammatory Diseases

4.2.2 Expansion Of Subcutaneous And Injectable Drug Delivery

4.2.3 Growing Clinical Trials And Research For Novel Anti-Inflammatory Biologics

4.2.4 Increased Focus On Personalized Treatment Plans

4.2.5 Rising Awareness And Access To Biologics In Emerging Markets

5. Anti-Inflammatory Biologics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Care Settings

5.4 Research And Academic Institutes

5.5 Specialty Care Centers

6. Anti-Inflammatory Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Inflammatory Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-Inflammatory Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anti-Inflammatory Biologics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anti-Inflammatory Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anti-Inflammatory Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Inflammatory Biologics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Inflammatory Biologics Market Segmentation

9.1. Global Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, B-Cell Inhibitors, T-Cell Inhibitors, Other Drug Classes

9.2. Global Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injection, Intravenous, Subcutaneous

9.3. Global Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis, Other Applications

9.4. Global Anti-Inflammatory Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.5. Global Anti-Inflammatory Biologics Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Clinics, Home Care Settings, Research And Academic Institutes

9.6. Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adalimumab, Infliximab, Etanercept, Golimumab, Certolizumab Pegol

9.7. Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interleukin-1 Inhibitors, Interleukin-6 Inhibitors, Interleukin -12 Or 23 Inhibitors, Interleukin -17 Inhibitors, Interleukin -23 Inhibitors

9.8. Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of B-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rituximab, Ocrelizumab, Ofatumumab

9.9. Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of T-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Abatacept, Alefacept

9.10. Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Janus Kinase Inhibitors, Anti-IgE And Other Biologics

10. Anti-Inflammatory Biologics Market Regional And Country Analysis

10.1. Global Anti-Inflammatory Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anti-Inflammatory Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Inflammatory Biologics Market

11.1. Asia-Pacific Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Inflammatory Biologics Market

12.1. China Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Inflammatory Biologics Market

13.1. India Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Inflammatory Biologics Market

14.1. Japan Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Inflammatory Biologics Market

15.1. Australia Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Inflammatory Biologics Market

16.1. Indonesia Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Inflammatory Biologics Market

17.1. South Korea Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Inflammatory Biologics Market

18.1. Taiwan Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Inflammatory Biologics Market

19.1. South East Asia Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Inflammatory Biologics Market

20.1. Western Europe Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Inflammatory Biologics Market

21.1. UK Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Inflammatory Biologics Market

22.1. Germany Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Inflammatory Biologics Market

23.1. France Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Inflammatory Biologics Market

24.1. Italy Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Inflammatory Biologics Market

25.1. Spain Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Inflammatory Biologics Market

26.1. Eastern Europe Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Inflammatory Biologics Market

27.1. Russia Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Inflammatory Biologics Market

28.1. North America Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Inflammatory Biologics Market

29.1. USA Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Inflammatory Biologics Market

30.1. Canada Anti-Inflammatory Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Inflammatory Biologics Market

31.1. South America Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Inflammatory Biologics Market

32.1. Brazil Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Inflammatory Biologics Market

33.1. Middle East Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Inflammatory Biologics Market

34.1. Africa Anti-Inflammatory Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Inflammatory Biologics Market Regulatory and Investment Landscape

36. Anti-Inflammatory Biologics Market Competitive Landscape And Company Profiles

36.1. Anti-Inflammatory Biologics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anti-Inflammatory Biologics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anti-Inflammatory Biologics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Inflammatory Biologics Market Other Major And Innovative Companies

Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc, UCB S.A, UCB S.A./N.V

38. Global Anti-Inflammatory Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Inflammatory Biologics Market

40. Anti-Inflammatory Biologics Market High Potential Countries, Segments and Strategies

40.1 Anti-Inflammatory Biologics Market In 2030 - Countries Offering Most New Opportunities

40.2 Anti-Inflammatory Biologics Market In 2030 - Segments Offering Most New Opportunities

40.3 Anti-Inflammatory Biologics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anti-Inflammatory Biologics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anti-Inflammatory Biologics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anti-Inflammatory Biologics Market, Supply Chain Analysis
  • Table 4: Global Anti-Inflammatory Biologics Market, Major Raw Material Providers
  • Table 5: Global Anti-Inflammatory Biologics Market, Major Resource Providers
  • Table 6: Global Anti-Inflammatory Biologics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anti-Inflammatory Biologics Market, Major Distributors And Channel Partners
  • Table 8: Global Anti-Inflammatory Biologics Market, Key Technologies & Future Trends
  • Table 9: Global Anti-Inflammatory Biologics Market, Major Trends
  • Table 10: Global Anti-Inflammatory Biologics Market, Major End Users
  • Table 11: Global Anti-Inflammatory Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anti-Inflammatory Biologics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anti-Inflammatory Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anti-Inflammatory Biologics Market - TAM, US$ Billion, 2025
  • Table 15: Global Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anti-Inflammatory Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anti-Inflammatory Biologics Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of B-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of T-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Anti-Inflammatory Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Anti-Inflammatory Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Anti-Inflammatory Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Anti-Inflammatory Biologics Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Johnson And Johnson Financial Performance
  • Table 103: Roche Holding AG Financial Performance
  • Table 104: AbbVie Inc Financial Performance
  • Table 105: Sanofi S.A Financial Performance
  • Table 106: Global Anti-Inflammatory Biologics Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Anti-Inflammatory Biologics Market, Competitive Dashboard
  • Table 108: Global Anti-Inflammatory Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 110: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 111: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Anti-Inflammatory Biologics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anti-Inflammatory Biologics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anti-Inflammatory Biologics Market, Supply Chain Analysis
  • Figure 4: Global Anti-Inflammatory Biologics Market, Major Raw Material Providers
  • Figure 5: Global Anti-Inflammatory Biologics Market, Major Resource Providers
  • Figure 6: Global Anti-Inflammatory Biologics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anti-Inflammatory Biologics Market, Major Distributors And Channel Partners
  • Figure 8: Global Anti-Inflammatory Biologics Market, Key Technologies & Future Trends
  • Figure 9: Global Anti-Inflammatory Biologics Market, Major Trends
  • Figure 10: Global Anti-Inflammatory Biologics Market, Major End Users
  • Figure 11: Global Anti-Inflammatory Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anti-Inflammatory Biologics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anti-Inflammatory Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anti-Inflammatory Biologics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anti-Inflammatory Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anti-Inflammatory Biologics Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of B-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of T-Cell Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Anti-Inflammatory Biologics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Anti-Inflammatory Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Anti-Inflammatory Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Anti-Inflammatory Biologics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Anti-Inflammatory Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Anti-Inflammatory Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Anti-Inflammatory Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Anti-Inflammatory Biologics Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Johnson And Johnson Financial Performance
  • Figure 103: Roche Holding AG Financial Performance
  • Figure 104: AbbVie Inc Financial Performance
  • Figure 105: Sanofi S.A Financial Performance
  • Figure 106: Global Anti-Inflammatory Biologics Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Anti-Inflammatory Biologics Market, Competitive Dashboard
  • Figure 108: Global Anti-Inflammatory Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 110: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 111: Global, Anti-Inflammatory Biologics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Anti-Inflammatory Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics), By Indication (Arthritis, Respiratory Dise...

Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Global Outlook – By Route Of Administration (Oral, Topical, Other Route Of Administration), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Othe...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Rheumatology Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes), By Dist...

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Wound Care Biologics Market Report 2026 - Global Outlook – By Product (Biologic Skin Substitutes, Topical Agents), By Wound Type (Ulcers, Surgical, Traumatic Wounds, Burns), By End User (Hospitals, Ambulatory Surgery Cen...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Rheumatoid Arthritis Drugs Market Report 2026 - Global Outlook – By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (...

Frequently Asked Questions

The Anti-Inflammatory Biologics market was valued at $118.02 billion in 2025, increased to $128.84 billion in 2026, and is projected to reach $180.93 billion by 2030.

The global Anti-Inflammatory Biologics market is expected to grow at a CAGR of 8.9% from 2026 to 2035 to reach $180.93 billion by 2035.

Some Key Players in the Anti-Inflammatory Biologics market Include, Pfizer Inc., Johnson And Johnson, Roche Holding AG, AbbVie Inc, Sanofi S.A, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc, UCB S.A .

Major trend in this market includes: Targeted IL-6 Therapies Offer Safer Relief For Chronic Inflammatory Conditions. For further insights on this market. request a sample here

North America was the largest region in the anti-inflammatory biologics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us